Modification of the effect of vitamin A acid on the skin tumor keratoacanthoma by applications of actinomcin D.
D000818:Animals; D001551:Benz(a)Anthracenes; D003609:Dactinomycin / Q000627:therapeutic use*; D004721:Endoplasmic Reticulum; D006003:Glycogen / Q000378:metabolism; D006056:Golgi Apparatus; D002479:Inclusion Bodies; D007636:Keratoacanthoma / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D008264:Macrophages; D008297:Male; D008854:Microscopy, Electron; D009093:Mucus / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology; D011817:Rabbits; D012270:Ribosomes; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000139:chemically induced / Q000188:drug therapy*; D014801:Vitamin A / Q000037:antagonists & inhibitors*
D001551:Benz(a)Anthracenes; D014801:Vitamin A; D003609:Dactinomycin; D006003:Glycogen